To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene FLJ10357TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
280 supporting clones for gene FLJ10357 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
AK074057 Spleen .a 1 to 5178 1 to 5178 A4G V983L L1216S tiling clone, available from FLJ,   5178/5178
(100 %)
4 diff
(100.0 %id)
NM_018071.3   .a 54 to 5511 1 to 5458   RefSeq,   5458/5458
(100 %)
0 diff
(100 %id)
CV801670 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 324 to 1002 1 to 668       668/806
(82 %)
15 diff
(98.2 %id)
BQ716727 sympathetic trunk .a 475 to 1140 1 to 675       675/972
(69 %)
8 diff
(99.2 %id)
BX388838 Placenta Cot 25-normalized .a 682 to 1177 19 to 515       497/537
(92 %)
7 diff
(98.7 %id)
BG393203 embryonal carcinoma, cell line, testis .a 682 to 1383 1 to 706       706/706
(100 %)
19 diff
(97.4 %id)
BX369855 Placenta Cot 25-normalized .a 700 to 1158 41 to 498       458/498
(91 %)
6 diff
(98.8 %id)
AK024463 Spleen .a 720 to 5178 13 to 4471   available from FLJ,   4459/4471
(99 %)
8 diff
(99.9 %id)
BX367796 Placenta Cot 25-normalized .a 799 to 1428 26 to 632       607/663
(91 %)
6 diff
(99.1 %id)
CN266531 embryonic stem cells, cell lines H1, H7, andH9 .a 1085 to 1229 8 to 152       145/152
(95 %)
6 diff
(96.1 %id)
BX377016 Placenta Cot 25-normalized .a 1135 to 1656 8 to 531       524/531
(98 %)
23 diff
(95.7 %id)
BU554102 ovary, teratocarcinoma, cell line .a 1269 to 2000 19 to 752       734/946
(77 %)
18 diff
(98.1 %id)
BU553955 ovary, teratocarcinoma, cell line .a 1278 to 2121 1 to 847       847/866
(97 %)
15 diff
(98.3 %id)
BU931982 ovary, teratocarcinoma, cell line .a 1278 to 2194 1 to 926       926/936
(98 %)
14 diff
(98.6 %id)
BF922570 nervous_tumor .a 1312 to 1605 298 to 5     Submitted on the opposite strand 294/328
(89 %)
0 diff
(100 %id)
BF922582 nervous_tumor .a 1344 to 1605 273 to 5     Submitted on the opposite strand 269/308
(87 %)
10 diff
(96.8 %id)
BM011796 brain, neuroblastoma, cell line .a 1380 to 1886 1 to 514       513/514
(99 %)
23 diff
(95.6 %id)
BP420357 small intestine .a 1381 to 1884 1 to 504     Submitted on the opposite strand 504/504
(100 %)
0 diff
(100 %id)
TI_59380971   .a 1381 to 1886 91 to 603       512/513
(99 %)
22 diff
(95.8 %id)
BQ948905 brain, neuroblastoma, cell line .a 1382 to 2225 1 to 845       845/917
(92 %)
13 diff
(98.6 %id)
CX787204 human embryonic stem cells .a 1663 to 2406 1 to 744       744/744
(100 %)
1 diff
(99.9 %id)
CN343461 embryonic stem cells, cell lines H1, H7, andH9 .a 1678 to 2340 1 to 664       664/664
(100 %)
3 diff
(99.6 %id)
CN343465 embryonic stem cells, cell lines H1, H7, andH9 .a 1789 to 2458 1 to 669       669/669
(100 %)
3 diff
(99.6 %id)
CN343463 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 1810 to 2195 1 to 387       387/387
(100 %)
5 diff
(98.8 %id)
CN343464 embryonic stem cells, cell lines H1, H7, andH9 .a 2021 to 2612 1 to 592       592/592
(100 %)
0 diff
(100 %id)
TI_2194644976   .a 2141 to 3262 11 to 1123       1113/1260
(88 %)
26 diff
(98.0 %id)
CV814114 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2185 to 2821 40 to 679       640/733
(87 %)
30 diff
(96.0 %id)
CV815700 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 2190 to 2873 1 to 681       681/681
(100 %)
11 diff
(98.4 %id)
BM008711 adenocarcinoma, Pancreas .a 2204 to 2818 2 to 617       616/617
(99 %)
2 diff
(99.7 %id)
TI_59386420   .a 2204 to 2818 65 to 680       616/616
(100 %)
2 diff
(99.7 %id)
BU155099 melanotic melanoma, skin .a 2305 to 3008 35 to 745       711/922
(77 %)
34 diff
(96.4 %id)
BX502337 Liver .a 2359 to 2850 1 to 492       492/492
(100 %)
1 diff
(99.8 %id)
BE868452 adenocarcinoma, colon .a 2394 to 2578 1 to 187       187/187
(100 %)
6 diff
(96.8 %id)
DA803985 brain .a 2471 to 3006 2 to 537   capped   536/536
(100 %)
2 diff
(99.7 %id)
BF312008 brain, neuroblastoma .a 2536 to 3133 1 to 624   available from MGC,   622/905
(68 %)
39 diff
(95.7 %id)
BC009992 Brain, neuroblastoma .a 2537 to 5178 1 to 2642   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 2642/2642
(100 %)
0 diff
(100 %id)
BG750105 eye, normal pigmented retinal epithelium .a 2547 to 3333 1 to 792       792/855
(92 %)
18 diff
(97.9 %id)
BE312800 brain, neuroblastoma .a 2556 to 3232 1 to 676       676/1071
(63 %)
19 diff
(98.3 %id)
DR004041 Liver .a 2605 to 2873 18 to 286       269/286
(94 %)
7 diff
(97.6 %id)
BM008444 Spleen .a 2800 to 3538 1 to 724       724/820
(88 %)
30 diff
(96.4 %id)
TI_59383177   .a 2806 to 3538 121 to 841       721/817
(88 %)
39 diff
(95.3 %id)
DB202390 trachea .a 2918 to 3495 2 to 579   capped   578/578
(100 %)
2 diff
(99.7 %id)
CX866954 embryonic stem .a 2940 to 3722 1 to 783       783/783
(100 %)
2 diff
(99.8 %id)
BG825622 muscle, rhabdomyosarcoma .a 3116 to 3826 1 to 711       711/715
(99 %)
6 diff
(99.2 %id)
BG762275 melanotic melanoma, high MDR (cell line), skin .a 3120 to 3841 1 to 719       719/719
(100 %)
5 diff
(99.4 %id)
BF526608 brain, glioblastoma with EGFR amplification .a 3134 to 3724 1 to 605       603/605
(99 %)
24 diff
(96.1 %id)
BG750376 eye, normal pigmented retinal epithelium .a 3160 to 4008 1 to 851       851/855
(99 %)
8 diff
(99.1 %id)
BG750458 eye, normal pigmented retinal epithelium .a 3160 to 4040 1 to 888       886/971
(91 %)
33 diff
(96.7 %id)
BU930877 ovary, teratocarcinoma, cell line .a 3182 to 4021 1 to 854       854/917
(93 %)
32 diff
(96.6 %id)
BU553593 ovary, teratocarcinoma, cell line .a 3183 to 4007 1 to 825       825/873
(94 %)
3 diff
(99.7 %id)
BU849114 ovary, teratocarcinoma, cell line .a 3183 to 4042 1 to 866       866/913
(94 %)
10 diff
(99.0 %id)
TI_2194644968   .a 3234 to 4319 1 to 1078       1078/1263
(85 %)
13 diff
(99.0 %id)
BY799990 eye .a 3284 to 3847 1 to 564       564/564
(100 %)
4 diff
(99.3 %id)
BG913569 anaplastic oligodendroglioma with 1p/19qloss, brain .a 3308 to 3724 65 to 481       417/481
(86 %)
7 diff
(98.6 %id)
TI_2194644969   .a 3326 to 4036 98 to 805       708/1155
(61 %)
42 diff
(96.4 %id)
BQ326756 colon_normal .a 3335 to 3710 43 to 420       378/420
(90 %)
12 diff
(97.2 %id)
BG422673 Kidney, renal cell adenocarcinoma .a 3395 to 4042 1 to 645       645/968
(66 %)
10 diff
(99.0 %id)
BC000084 Kidney, renal cell adenocarcinoma .a 3396 to 5178 1 to 1783   available from MGC, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 1783/1783
(100 %)
2 diff
(99.9 %id)
BQ707631 Spleen .a 3439 to 4219 1 to 776       776/972
(79 %)
20 diff
(98.0 %id)
CN343468 embryonic stem cells, cell lines H1, H7, andH9 .a 3496 to 4232 1 to 738       738/738
(100 %)
5 diff
(99.4 %id)
CF264785 Brain glioblastoma .a 3540 to 4225 1 to 693       693/900
(77 %)
18 diff
(98.0 %id)
BE709982 head_neck .a 3566 to 3991 15 to 440       426/440
(96 %)
6 diff
(98.7 %id)
BF310119 muscle, rhabdomyosarcoma .a 3567 to 4222 1 to 654       654/748
(87 %)
35 diff
(95.4 %id)
BQ881434 dorsal root ganglia .a 3569 to 4436 1 to 878       878/958
(91 %)
24 diff
(97.5 %id)
CD579278 brain .a 3594 to 4298 1 to 704       704/973
(72 %)
17 diff
(98.3 %id)
AU123875   .a 3597 to 4293 2 to 702   capped   701/801
(87 %)
6 diff
(99.3 %id)
CN343469 embryonic stem cells, cell lines H1, H7, andH9 .a 3609 to 4092 1 to 486       486/486
(100 %)
11 diff
(97.8 %id)
BQ898057 dorsal root ganglia .a 3612 to 4469 1 to 869       869/936
(92 %)
18 diff
(98.1 %id)
F11710 brain, total brain .a 3623 to 3971 1 to 349       349/349
(100 %)
2 diff
(99.5 %id)
R18386 whole brain .a 3624 to 4084 1 to 465       465/468
(99 %)
14 diff
(97.1 %id)
R35159 whole brain .a 3624 to 4050 1 to 434       434/498
(87 %)
21 diff
(95.8 %id)
BM463863 melanotic melanoma, skin .a 3624 to 4469 1 to 852       852/1102
(77 %)
18 diff
(98.4 %id)
TI_1948091343   .a 3661 to 4470 138 to 947       810/1441
(56 %)
14 diff
(99.1 %id)
TI_1948091457   .a 3661 to 4605 131 to 1077       947/1367
(69 %)
38 diff
(97.3 %id)
TI_1948091703   .a 3661 to 4599 131 to 1067       937/1366
(68 %)
25 diff
(98.2 %id)
CV028247 mixed .a 3662 to 4089 1 to 428       428/428
(100 %)
27 diff
(93.7 %id)
BM542357 melanotic melanoma, skin .a 3704 to 4252 1 to 551       551/1231
(44 %)
9 diff
(99.3 %id)
CX784489 human embryonic stem cells .a 3819 to 4611 1 to 793       793/793
(100 %)
1 diff
(99.9 %id)
AA345181 gall bladder .a 4063 to 4274 1 to 212       212/212
(100 %)
0 diff
(100 %id)
AW963228   .a 4064 to 4802 1 to 740       740/741
(99 %)
6 diff
(99.2 %id)
BX347093 Placenta Cot 25-normalized .a 4114 to 4572 460 to 5       456/460
(99 %)
6 diff
(98.7 %id)
BQ918979 large cell carcinoma, lung .a 4154 to 4962 1 to 825       825/899
(91 %)
19 diff
(97.9 %id)
BM931081 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 4191 to 4631 1 to 445   fully sequenced, Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 445/445
(100 %)
4 diff
(99.2 %id)
BG748815 eye, normal pigmented retinal epithelium .a 4197 to 5014 1 to 816       816/816
(100 %)
6 diff
(99.3 %id)
CX754055 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .a 4198 to 4931 40 to 773     Submitted on the opposite strand 734/773
(94 %)
6 diff
(99.3 %id)
BX355557 Placenta Cot 25-normalized .a 4225 to 5162 938 to 1       938/938
(100 %)
18 diff
(98.1 %id)
W65329 heart .a 4256 to 4729 1 to 477       477/478
(99 %)
20 diff
(95.9 %id)
AA303133 uterus .a 4279 to 4500 1 to 224       224/224
(100 %)
2 diff
(99.2 %id)
AW954137   .a 4280 to 5007 1 to 724       724/725
(99 %)
10 diff
(98.7 %id)
BM509413 insulinoma, Pancreas .a 4298 to 4798 1 to 501       501/501
(100 %)
5 diff
(99.1 %id)
BM684546 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 4570 to 5178 627 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 609/609
(100 %)
1 diff
(99.9 %id)
TI_2194644971   .a 4605 to 4957 8 to 359       352/1263
(27 %)
7 diff
(99.5 %id)
CK903396 Islets of Langerhans, Pancreas .a 4644 to 5179 541 to 6       536/543
(98 %)
0 diff
(100 %id)
AW862232 colon .a 4647 to 4968 334 to 11       324/335
(96 %)
0 diff
(100 %id)
AW862233 colon .a 4647 to 4959 314 to 1       314/315
(99 %)
10 diff
(96.9 %id)
AW862234 colon .a 4647 to 4946 300 to 1       300/301
(99 %)
5 diff
(98.4 %id)
BQ317010 colon .a 4647 to 4968 330 to 4       327/331
(98 %)
0 diff
(100 %id)
BU625247 cell lines, Enchondroma .a 4654 to 5179 543 to 18       526/543
(96 %)
0 diff
(100 %id)
BM698288 eye, fetal eyes .a 4655 to 5050 1 to 396       396/396
(100 %)
0 diff
(100 %id)
AI039196   .a 4677 to 5179 499 to 4       496/499
(99 %)
0 diff
(100 %id)
BI963137 Islets of Langerhans, Pancreas .a 4679 to 5179 505 to 6       500/505
(99 %)
0 diff
(100 %id)
BU581209 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .a 4681 to 5177 497 to 1       497/497
(100 %)
0 diff
(100 %id)
AA778210 liver and spleen .a 4684 to 5189 506 to 1       506/506
(100 %)
4 diff
(99.3 %id)
BF326550 breast_normal .a 4691 to 4968 1 to 282       282/282
(100 %)
13 diff
(95.4 %id)
CX866881 embryonic stem .a 4691 to 5187 528 to 32       497/528
(94 %)
0 diff
(100 %id)
R69490 breast .a 4697 to 5091 1 to 399       399/399
(100 %)
11 diff
(97.3 %id)
AI056078   .a 4698 to 5179 484 to 4       481/484
(99 %)
0 diff
(100 %id)
BI001077 head_normal .a 4703 to 4972 10 to 277       268/278
(96 %)
14 diff
(95.0 %id)
AW173000 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 4705 to 5179 476 to 2       475/476
(99 %)
0 diff
(100 %id)
BE677802 pooled .a 4708 to 5179 475 to 4       472/475
(99 %)
0 diff
(100 %id)
AW118613 pooled .a 4718 to 5179 465 to 4       462/465
(99 %)
0 diff
(100 %id)
AI770118 2 pooled tumors (clear cell type), Kidney .a 4720 to 5179 461 to 3       459/461
(99 %)
0 diff
(100 %id)
AA705287 liver and spleen .a 4722 to 5179 457 to 1       457/457
(100 %)
3 diff
(99.4 %id)
BF593772 brain, glioblastoma (pooled) .a 4728 to 5178 451 to 1       451/451
(100 %)
0 diff
(100 %id)
AI619459 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 4730 to 5178 449 to 1       449/449
(100 %)
0 diff
(100 %id)
BP396848 pancreatic islet .a 4737 to 5179 1 to 443     Submitted on the opposite strand 443/447
(99 %)
1 diff
(99.8 %id)
AI864689 pooled .a 4738 to 5178 453 to 13   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 441/441
(100 %)
0 diff
(100 %id)
BM992998 lung, Metastatic Chondrosarcoma .a 4741 to 5178 454 to 17   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 438/438
(100 %)
0 diff
(100 %id)
AA303134 uterus .a 4762 to 5178 417 to 1       417/417
(100 %)
2 diff
(99.6 %id)
AA595426 Prostate, prostate tumor .a 4762 to 5179 418 to 2       417/418
(99 %)
0 diff
(100 %id)
AI983155 adenocarcinoma, Pancreas .a 4763 to 5179 419 to 2       418/419
(99 %)
0 diff
(100 %id)
AA829341 lung, small cell carcinoma .a 4773 to 5178 423 to 20   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 404/404
(100 %)
2 diff
(99.6 %id)
AI201690 anaplastic oligodendroglioma, brain .a 4773 to 5178 406 to 1       406/406
(100 %)
0 diff
(100 %id)
R69617 placenta .a 4775 to 5177 404 to 1       404/407
(99 %)
4 diff
(99.1 %id)
AA954907 Kidney, kidney tumor .a 4778 to 5178 400 to 1       400/400
(100 %)
1 diff
(99.8 %id)
AI337973 uterus .a 4783 to 5179 398 to 2       397/398
(99 %)
0 diff
(100 %id)
AI190961 heart .a 4787 to 5178 392 to 1       392/392
(100 %)
0 diff
(100 %id)
R50818 whole brain .a 4788 to 5179 412 to 9       404/412
(98 %)
0 diff
(100 %id)
AI916385 Kidney .a 4793 to 5191 402 to 5       398/402
(99 %)
0 diff
(100 %id)
BG054959 brain, glioblastoma (pooled) .a 4801 to 5178 378 to 1       378/378
(100 %)
0 diff
(100 %id)
W61312 heart .a 4803 to 5189 388 to 1       388/388
(100 %)
2 diff
(99.5 %id)
AI471872 Kidney .a 4804 to 5179 377 to 2       376/377
(99 %)
0 diff
(100 %id)
R42449 whole brain .a 4807 to 5179 392 to 9       384/431
(89 %)
0 diff
(100 %id)
AW295614   .a 4811 to 5179 385 to 17       369/385
(95 %)
0 diff
(100 %id)
AW592988 pooled .a 4811 to 5179 370 to 3       368/373
(98 %)
0 diff
(100 %id)
AI446011 adenocarcinoma, Pancreas .a 4814 to 5178 365 to 1       365/365
(100 %)
0 diff
(100 %id)
AI700351 colon .a 4815 to 5178 364 to 1       364/364
(100 %)
0 diff
(100 %id)
AI858735 anaplastic oligodendroglioma, brain .a 4818 to 5178 361 to 1       361/361
(100 %)
0 diff
(100 %id)
BQ025726 placenta .a 4823 to 5178 372 to 17   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 356/356
(100 %)
2 diff
(99.5 %id)
AA884118 pooled .a 4830 to 5179 352 to 3       350/352
(99 %)
0 diff
(100 %id)
AW298604   .a 4831 to 5179 365 to 17       349/365
(95 %)
0 diff
(100 %id)
AW008931 colon .a 4839 to 5179 341 to 1       341/341
(100 %)
0 diff
(100 %id)
AI368258 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .a 4859 to 5179 345 to 25       321/345
(93 %)
0 diff
(100 %id)
F09368 brain, total brain .a 4865 to 5178 314 to 1       314/314
(100 %)
0 diff
(100 %id)
AA961503 pooled .a 4873 to 5174 302 to 1       302/302
(100 %)
1 diff
(99.7 %id)
AW016820   .a 4877 to 5179 319 to 17       303/319
(94 %)
0 diff
(100 %id)
AW274429 Kidney .a 4899 to 5178 284 to 1       284/284
(100 %)
9 diff
(96.9 %id)
R70384.
matches multiple genes
breast .a 4918 to 5189 279 to 1     also hits gene ZMYM6 279/282
(98 %)
4 diff
(98.6 %id)
AI381321   .a 4952 to 5179 230 to 3       228/230
(99 %)
0 diff
(100 %id)
AI572841 Kidney .a 4969 to 5191 228 to 6   tiling clone,   223/228
(97 %)
0 diff
(100 %id)
BC144317 Pooled, cerebellum, kidney, placenta,testis, lung, colon, liver, heart, thyroid, bladder,uterus, PCR rescued clones .b 1 to 4669 1 to 4670 V415L L648S tiling clone,   4670/4670
(100 %)
3 diff
(100.0 %id)
TI_2194644972   .b 628 to 1753 13 to 1134   tiling clone,   1122/1269
(88 %)
26 diff
(98.0 %id)
TI_2194644974   .b 1260 to 2409 9 to 1146       1140/1260
(90 %)
18 diff
(98.6 %id)
TI_2194644975   .b 1514 to 2557 15 to 1051       1037/1232
(84 %)
16 diff
(98.8 %id)
CR618390 fetal brain .b 3288 to 4877 1 to 1590       1590/1590
(100 %)
0 diff
(100 %id)
BX421033 brain, fetal brain .b 3289 to 4108 1 to 819   fully sequenced,   819/819
(100 %)
10 diff
(98.8 %id)
AK001219   .b 3453 to 4902 1 to 1450   tiling clone, available from FLJ,   1450/1450
(100 %)
0 diff
(100 %id)
CN343462 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 3504 to 4220 8 to 725       718/725
(99 %)
7 diff
(99.1 %id)
TI_2194644138   .b 3518 to 4670 1256 to 117       1140/1292
(88 %)
36 diff
(97.3 %id)
BM478492 eye, retinoblastoma .b 3636 to 4550 1 to 926       926/1132
(81 %)
42 diff
(96.3 %id)
TI_2194645998   .b 3727 to 4670 1061 to 116       946/1300
(72 %)
4 diff
(99.7 %id)
TI_2194644970   .b 3902 to 4670 11 to 778       768/1252
(61 %)
7 diff
(99.5 %id)
BF951373 nervous_normal .b 3908 to 4335 20 to 447       428/447
(95 %)
8 diff
(98.3 %id)
BX421032 brain, fetal brain .b 4047 to 4877 830 to 1   fully sequenced,   830/830
(100 %)
4 diff
(99.6 %id)
BU581511 Fetal Pancreas (4 Pooled Donors, 18 - 20weeks, Stratagene #738023) .b 4137 to 4774 11 to 649       639/649
(98 %)
7 diff
(99.0 %id)
BF339938 brain, glioblastoma with EGFR amplification .b 4425 to 5224 1 to 782       782/931
(83 %)
37 diff
(96.1 %id)
T97121 liver and spleen .b 4697 to 4981 1 to 288       288/288
(100 %)
3 diff
(99.0 %id)
BQ447317 Knee, Osteoarthritic Cartilage .b 4834 to 5586 763 to 18   tiling clone, AAA   746/751
(99 %)
10 diff
(98.7 %id)
AA203208 liver and spleen .b 4856 to 5391 1 to 527       527/814
(64 %)
10 diff
(98.8 %id)
CA430017 Cell Line, Chondrosarcoma .b 4903 to 5592 708 to 19   AAA   690/690
(100 %)
10 diff
(98.6 %id)
AV681494 hepatocellular carcinoma .b 4974 to 5589 84 to 696   AAA   613/696
(88 %)
23 diff
(96.7 %id)
BU597701 mixed (pool of 40 RNAs) .b 5000 to 5591 1 to 592       592/593
(99 %)
1 diff
(99.9 %id)
BQ447551 Knee, Osteoarthritic Cartilage .b 5017 to 5592 593 to 19   AAA   575/575
(100 %)
3 diff
(99.5 %id)
AI186984 lung .b 5105 to 5587 483 to 1       483/483
(100 %)
1 diff
(99.8 %id)
BM509169 insulinoma, Pancreas .b 5106 to 5574 469 to 1       469/469
(100 %)
0 diff
(100 %id)
AA699723 liver and spleen .b 5109 to 5592 483 to 1       483/483
(100 %)
3 diff
(99.4 %id)
AA587865 adrenal adenoma, adrenal gland .b 5125 to 5594 471 to 1       471/471
(100 %)
4 diff
(99.2 %id)
AI218228 pooled .b 5132 to 5595 464 to 1       464/464
(100 %)
0 diff
(100 %id)
AW511447 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .b 5133 to 5595 463 to 1       463/463
(100 %)
1 diff
(99.8 %id)
AW149832 brain, medulloblastoma .b 5146 to 5595 454 to 4       451/454
(99 %)
0 diff
(100 %id)
BQ025712 placenta .b 5146 to 5592 466 to 19   AAA   448/448
(100 %)
2 diff
(99.6 %id)
AI075775 liver and spleen .b 5154 to 5590 437 to 1       437/437
(100 %)
0 diff
(100 %id)
BE858257 brain, glioblastoma (pooled) .b 5160 to 5592 433 to 1       433/433
(100 %)
0 diff
(100 %id)
BG056219 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .b 5160 to 5593 434 to 1       434/434
(100 %)
1 diff
(99.8 %id)
AI089713 brain, glioblastoma (pooled) .b 5185 to 5595 414 to 4       411/414
(99 %)
0 diff
(100 %id)
AA620676   .b 5193 to 5589 396 to 1       396/396
(100 %)
5 diff
(98.8 %id)
AA705153 liver and spleen .b 5197 to 5591 393 to 2       392/393
(99 %)
0 diff
(100 %id)
AI937447 anaplastic oligodendroglioma, brain .b 5224 to 5592 390 to 25   AAA   366/366
(100 %)
0 diff
(100 %id)
AI202281 Prostate .b 5233 to 5589 358 to 1       358/358
(100 %)
1 diff
(99.8 %id)
AI928705 anaplastic oligodendroglioma, brain .b 5236 to 5595 371 to 12       360/371
(97 %)
0 diff
(100 %id)
T72160 Liver .b 5255 to 5590 340 to 1       340/340
(100 %)
10 diff
(97.1 %id)
AA431431   .b 5271 to 5589 335 to 17   AAA   319/319
(100 %)
4 diff
(98.8 %id)
AI653220 pooled germ cell tumors .b 5275 to 5589 341 to 27   AAA   315/315
(100 %)
9 diff
(97.2 %id)
T97006 liver and spleen .b 5286 to 5574 290 to 1       290/420
(69 %)
3 diff
(99.3 %id)
CD249950 embryonic stem cells, WA01, passage 38 .b 5315 to 5589 25 to 298   AAA   274/298
(91 %)
6 diff
(98.0 %id)
AI928047 normal prostate, Prostate .b 5394 to 5595 204 to 3       202/204
(99 %)
0 diff
(100 %id)
AA620361   .b 5407 to 5595 190 to 3       188/190
(98 %)
0 diff
(100 %id)
AA039405 uterus .b 5423 to 5560 1 to 138   fully sequenced,   138/138
(100 %)
5 diff
(96.4 %id)
AW471304 adenocarcinoma, Pancreas .b 5423 to 5592 185 to 16   AAA   170/170
(100 %)
3 diff
(98.3 %id)
CA841337 Pancreas, Purified pancreatic islet .b 5423 to 5777 31 to 385       355/385
(92 %)
6 diff
(98.5 %id)
CX166481 human embryonic stem cells differentiated toan early endodermal cell type .b 5425 to 6239 1 to 815   tiling clone,   815/815
(100 %)
0 diff
(100 %id)
BQ186914 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .b 5426 to 5799 44 to 417       374/417
(89 %)
0 diff
(100 %id)
TI_151732905   .b 5426 to 5801 430 to 55       376/1044
(36 %)
0 diff
(100 %id)
CX872629 embryonic stem .b 5431 to 6159 1 to 729       729/729
(100 %)
0 diff
(100 %id)
CX872711 embryonic stem .b 5432 to 6193 1 to 762       762/762
(100 %)
3 diff
(99.7 %id)
AA039285 uterus .b 5481 to 5560 79 to 1   fully sequenced,   79/79
(100 %)
1 diff
(98.8 %id)
BQ371737 prostate_normal .b 5496 to 5738 12 to 253       242/253
(95 %)
6 diff
(97.7 %id)
BM873349   .b 5504 to 5593 1 to 90       90/90
(100 %)
0 diff
(100 %id)
CX761812 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 5758 to 6468 709 to 1   tiling clone,   709/710
(99 %)
4 diff
(99.5 %id)
CA841074 Pancreas, Purified pancreatic islet .b 6909 to 7212 304 to 1   tiling clone,   304/304
(100 %)
0 diff
(100 %id)
BC142692 Donated clones,Novartis FGA collection .c 1 to 5203 1 to 5203 exact tiling clone, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 5203/5203
(100 %)
1 diff
(100.0 %id)
BC151212 Donated clones,Novartis FGA collection .c 1 to 5203 1 to 5203 exact AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 5203/5203
(100 %)
1 diff
(100.0 %id)
AL137291 testis .d 1 to 2925 1 to 2925 V116L L349S tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 2925/2927
(99 %)
4 diff
(99.9 %id)
CX871013 embryonic stem .d 1007 to 1746 1 to 740       740/744
(99 %)
8 diff
(99.0 %id)
R34205 placenta .d 2112 to 2478 1 to 379       379/416
(91 %)
21 diff
(95.0 %id)
TI_149289462   .d 2225 to 2927 784 to 82   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 703/704
(99 %)
8 diff
(98.9 %id)
BX092386 ovarian tumor, ovary .d 2364 to 2927 1 to 564   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 564/564
(100 %)
1 diff
(99.9 %id)
AA402736 ovarian tumor, ovary .d 2364 to 2925 1 to 561   fully sequenced,   561/561
(100 %)
2 diff
(99.7 %id)
BU681623 lung .d 2381 to 2927 563 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 547/547
(100 %)
2 diff
(99.7 %id)
AA402327 ovarian tumor, ovary .d 2486 to 2925 439 to 1   fully sequenced,   439/439
(100 %)
1 diff
(99.8 %id)
BX355558 Placenta Cot 25-normalized .e 1 to 1054 1 to 1044   tiling clone,   1044/1052
(99 %)
22 diff
(98.0 %id)
BX248768 placenta .e 4 to 1799 1 to 1796   tiling clone,   1796/1796
(100 %)
0 diff
(100 %id)
TI_2194644131   .e 22 to 1135 97 to 1197       1101/1276
(86 %)
36 diff
(97.2 %id)
TI_2194645618   .e 22 to 1145 96 to 1185       1055/1236
(85 %)
44 diff
(96.5 %id)
BU167044 melanotic melanoma, skin .e 34 to 609 1 to 583       583/968
(60 %)
19 diff
(98.1 %id)
BX377017 Placenta Cot 25-normalized .e 1174 to 2109 1 to 938   tiling clone,   938/938
(100 %)
7 diff
(99.3 %id)
AK126755 cerebellum .f 1 to 3901 2 to 3901 exact tiling clone, available from FLJ,   3901/3901
(100 %)
6 diff
(99.9 %id)
DA121076 cerebellum .f 1 to 537 2 to 538   capped   537/537
(100 %)
0 diff
(100 %id)
DB300497 cerebellum .f 3407 to 3901 496 to 1       496/504
(98 %)
1 diff
(99.9 %id)
CN343467 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .g-u 1 to 611 1 to 611 E20K W177C tiling clone,   611/611
(100 %)
2 diff
(99.7 %id)
BQ652553 hepatocellular carcinoma, cell line, Liver .g-u 27 to 654 23 to 659   tiling clone,   637/1018
(62 %)
16 diff
(98.5 %id)
BQ649515 hepatocellular carcinoma, cell line, Liver .g-u 28 to 908 1 to 882   tiling clone,   882/959
(91 %)
57 diff
(94.1 %id)
BG166359 hypernephroma, cell line, Kidney .h 1 to 721 1 to 724 R8G A9L S10R V11G A12R ... tiling clone,   724/724
(100 %)
18 diff
(97.6 %id)
CK903397 Islets of Langerhans, Pancreas .h 58 to 663 1 to 606       606/606
(100 %)
2 diff
(99.7 %id)
BI964720 Islets of Langerhans, Pancreas .h 74 to 569 1 to 496       496/496
(100 %)
2 diff
(99.6 %id)
BI160128 epithelioid carcinoma cell line, Pancreas .h 116 to 701 1 to 586       586/587
(99 %)
3 diff
(99.5 %id)
CD558440 White Matter .h 128 to 800 29 to 699   tiling clone,   673/910
(73 %)
13 diff
(98.6 %id)
CN343466 embryonic stem cells, cell lines H1, H7, andH9 .i 1 to 202 1 to 205 S16A V17S G18D R19A G20A ... tiling clone,   205/205
(100 %)
5 diff
(97.6 %id)
BM546529 brain, hippocampus .j-u 1 to 823 24 to 857 exact tiling clone,   834/1149
(72 %)
11 diff
(99.1 %id)
DA321182 hippocampus .j-u 311 to 879 2 to 569   tiling clone, capped   568/568
(100 %)
4 diff
(99.3 %id)
BF589981 Kidney .j-u 1552 to 2009 462 to 6   tiling clone,   457/462
(98 %)
0 diff
(100 %id)
BU620122 Cell Line, Chondrosarcoma .j-u 1777 to 2449 691 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 673/673
(100 %)
0 diff
(100 %id)
BU620348 Cell Line, Chondrosarcoma .j-u 1810 to 2449 653 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 635/641
(99 %)
7 diff
(99.0 %id)
DB309121 hippocampus .j-u 1890 to 2449 560 to 1       560/560
(100 %)
5 diff
(99.2 %id)
BQ025033 placenta .j-u 1922 to 2295 1 to 378     Submitted on the opposite strand 378/378
(100 %)
14 diff
(96.3 %id)
BQ025724 placenta .j-u 1922 to 2310 1 to 393     Submitted on the opposite strand 393/393
(100 %)
8 diff
(98.0 %id)
BQ022157 placenta .j-u 1923 to 2385 1 to 467     Submitted on the opposite strand 467/467
(100 %)
8 diff
(98.3 %id)
BX105950 placenta .j-u 1925 to 2452 528 to 1   tiling clone, Submitted on the opposite strand 528/532
(99 %)
0 diff
(100 %id)
AF147401   .j-u 1926 to 2449 1 to 524       524/524
(100 %)
0 diff
(100 %id)
R26903 placenta .j-u 1936 to 2186 1 to 256     Submitted on the opposite strand 256/294
(87 %)
8 diff
(97.3 %id)
R26912 placenta .j-u 1936 to 2248 1 to 327     Submitted on the opposite strand 327/355
(92 %)
19 diff
(94.7 %id)
H01005 placenta .j-u 1952 to 2262 1 to 314     Submitted on the opposite strand 314/314
(100 %)
3 diff
(99.1 %id)
R76550 placenta .j-u 1954 to 2331 1 to 388     Submitted on the opposite strand 388/474
(81 %)
16 diff
(96.7 %id)
AI640434 adenocarcinoma, Pancreas .j-u 2014 to 2449 436 to 1       436/436
(100 %)
0 diff
(100 %id)
BQ026439 placenta .j-u 2029 to 2449 438 to 18   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 421/421
(100 %)
0 diff
(100 %id)
R27140 placenta .j-u 2045 to 2450 414 to 1     Submitted on the opposite strand 414/414
(100 %)
22 diff
(94.7 %id)
R76272 placenta .j-u 2059 to 2449 404 to 1       404/406
(99 %)
16 diff
(96.1 %id)
FN148992 breast carcinoma .j-u 2071 to 2150 79 to 1     Submitted on the opposite strand 79/80
(98 %)
1 diff
(98.8 %id)
AA776972 heart .j-u 2076 to 2450 375 to 1       375/375
(100 %)
0 diff
(100 %id)
H01751 placenta .j-u 2165 to 2449 289 to 1     Submitted on the opposite strand 289/299
(96 %)
5 diff
(98.4 %id)
R27486 placenta .j-u 2176 to 2450 280 to 1     Submitted on the opposite strand 280/280
(100 %)
5 diff
(98.3 %id)
CA503193 Human Lung Epithelial cells, lung .j-u 2224 to 2449 244 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 226/246
(91 %)
2 diff
(99.2 %id)
GD143328   .j-u 2370 to 2449 1 to 80   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 80/80
(100 %)
2 diff
(97.5 %id)
CB992708 placenta, pre-eclamptic placenta .k 1 to 363 27 to 393 P10X T38X A64G P65H P66X ... tiling clone,   367/398
(92 %)
12 diff
(97.0 %id)
CB996150 placenta, pre-eclamptic placenta .k 1 to 747 27 to 781 exact tiling clone,   755/863
(87 %)
17 diff
(98.1 %id)
T12467   .k 191 to 527 336 to 1       336/338
(99 %)
17 diff
(95.0 %id)
AW859042 colon .k 314 to 722 14 to 420       407/435
(93 %)
5 diff
(98.9 %id)
BF334449 colon .k 390 to 722 348 to 16       333/348
(95 %)
0 diff
(100 %id)
BF334450 colon .k 411 to 722 327 to 16       312/327
(95 %)
0 diff
(100 %id)
AA377676 synovial membrane .k 417 to 727 1 to 312   tiling clone,   312/312
(100 %)
1 diff
(99.7 %id)
BF931574 nervous_tumor .k 426 to 844 420 to 1     Submitted on the opposite strand 420/422
(99 %)
3 diff
(99.3 %id)
BF334446 colon .k 428 to 722 310 to 16       295/310
(95 %)
0 diff
(100 %id)
BF334451 colon .k 484 to 722 255 to 16       240/255
(94 %)
0 diff
(100 %id)
BG282773 adenocarcinoma, cell line, Prostate .k 577 to 1316 1 to 728   tiling clone,   728/970
(75 %)
28 diff
(97.2 %id)
CV415760 colon .k 621 to 722 120 to 16     Submitted on the opposite strand 105/120
(87 %)
0 diff
(100 %id)
R92836 liver and spleen .k 791 to 1074 1 to 286       286/286
(100 %)
9 diff
(96.9 %id)
BQ576261 Chondrosarcoma Grade II, Left Pelvis .k 812 to 1511 718 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 700/700
(100 %)
0 diff
(100 %id)
BQ897096 melanotic melanoma, cell line, skin .k 824 to 1317 1 to 500       500/987
(50 %)
10 diff
(99.0 %id)
BU173987 melanotic melanoma, cell line, skin .k 824 to 1655 1 to 835   tiling clone,   835/858
(97 %)
7 diff
(99.2 %id)
BU839074 melanotic melanoma, cell line, skin .k 824 to 1676 1 to 857   tiling clone,   857/929
(92 %)
28 diff
(97.0 %id)
BU624962 cell lines, Enchondroma .k 890 to 1511 640 to 19   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 622/622
(100 %)
1 diff
(99.9 %id)
BQ006174 Chondrosarcoma, Left Pelvis .k 893 to 1500 624 to 17   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 608/618
(98 %)
1 diff
(99.9 %id)
BM994640 lung, Metastatic Chondrosarcoma .k 904 to 1500 613 to 17   AAA Possibly primed on the genome, locally A rich (22/23 A in genome downstream of last aligned base) 597/597
(100 %)
0 diff
(100 %id)
CK003348 brain/CNS, Human Brain - Cerebellar Cortex .l-u 1 to 670 1 to 671 exact tiling clone,   671/671
(100 %)
5 diff
(99.3 %id)
AA861890   .l-u 57 to 517 458 to 1   tiling clone,   458/461
(99 %)
5 diff
(99.0 %id)
CD721811 eye, lacrimal gland .m-u 1 to 608 1 to 608 exact tiling clone,   608/608
(100 %)
0 diff
(100 %id)
AW664934 pooled .n 1 to 419 419 to 1 G14X S31R tiling clone,   419/420
(99 %)
2 diff
(99.6 %id)
BI008768 kidney_tumor .o-u 1 to 267 268 to 1 exact tiling clone,   268/268
(100 %)
8 diff
(97.1 %id)
BI032369 nervous_normal .p-u 1 to 122 1 to 122 P3L tiling clone,   122/122
(100 %)
5 diff
(96.0 %id)
AV650561 corresponding non cancerous liver tissue Gene FLJ10357, variant not shown         Submitted on the opposite strand, submitted on the opposite strand    
TI_2194644973   Gene FLJ10357, variant not shown         Suspected internal deletion, this clone was ignored    
DR977960 brain Gene FLJ10357, variant not shown         This clone was ignored    
BG420218 Kidney, renal cell adenocarcinoma Gene FLJ10357, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g-u, .h, .i, .j-u, .k, .l-u, .m-u, .n, .o-u, .p-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI